Viewing Study NCT03576651


Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2025-12-25 @ 9:54 PM
Study NCT ID: NCT03576651
Status: COMPLETED
Last Update Posted: 2020-01-07
First Post: 2018-06-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Compare the Pharmacokinetics of JHL1149 and Bevacizumab (Avastin) in Healthy Male Volunteers
Sponsor: JHL Biotech, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module